Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound levofloxacin hydrochloride soluble powder for treating respiratory diseases of poultry

A levofloxacin and respiratory system disease technology, applied in the field of compound levofloxacin hydrochloride soluble powder, can solve the problems of difficult clinical diagnosis and serious drug-resistant strains, so as to improve the body's immunity and control secondary infection , the effect of a reasonable formula

Inactive Publication Date: 2014-04-09
NANYANG XINXIANFENG PHARMA
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the epidemic disease in the farm is no longer a typical infectious disease, but a mixed infection caused by the joint action of various pathogens, as well as the secondary infection caused by the later stage of breeding, which brings great challenges to clinical diagnosis. Great difficulties also make the role of a single drug can no longer meet the current clinical needs
At the same time, due to the long-term abuse of antibiotics in livestock and poultry farming, the problem of drug-resistant strains has become more and more serious

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Example 1: Weigh the raw materials respectively according to the following proportions: 5g of levofloxacin hydrochloride, 4g of azithromycin, 4g of toadstool, 25g of licorice extract, 5g of carmetin, 4g of trimethoprim lactate; add anhydrous glucose to 100g and mix evenly to prepare a special-effect compound levofloxacin soluble powder for treating poultry respiratory diseases. The weight ratio of the anhydrous glucose and the oral glucose is 1:1, and the raw materials are all commercially available products.

Embodiment 2

[0036] Example 2: Weigh the raw materials respectively according to the following proportions: 2.5g of levofloxacin hydrochloride, 2.5g of azithromycin, 3g of toadstool, 29g of licorice extract, 8g of carmetin, 1g of trimethoprim lactate; add anhydrous glucose And oral glucose to 100g, mix evenly, promptly make a kind of compound levofloxacin soluble powder that is used for treating poultry respiratory system disease with special effect. The weight ratio of the anhydrous glucose and the oral glucose is 1:1, and the raw materials are all commercially available products.

Embodiment 3

[0037] Example 3: Weigh the raw materials respectively according to the following proportions: 9g of levofloxacin hydrochloride, 8g of azithromycin, 5.5g of toadstool, 11g of licorice extract, 3g of carmetin, 4.8g of trimethoprim lactate; add anhydrous glucose And oral glucose to 100g, mix evenly, promptly make a kind of compound levofloxacin soluble powder that is used for treating poultry respiratory system disease with special effect. The weight ratio of the anhydrous glucose and oral glucose is 1:1. The raw materials are all commercially available products.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses compound levofloxacin hydrochloride soluble powder for treating respiratory diseases of poultry. The soluble powder is prepared by uniformly mixing the following components in percentage by weight: 2-10 percent of levofloxacin hydrochloride, 2-10 percent of azithromycin, 2-6 percent of venenum bufonis, 10-30 percent of liquorice extract, 3-9 percent of Kameiding, 1-5 percent of trimethoprim lactate, and the balance of pharmaceutically applicable auxiliaries. The compound preparation is compounded by latest market medicines, traditional Chinese medicinal extracts, novel antiasthmatic drugs and medicinal synergistic agents, and fatal factors are comprehensively taken, so that the compound levofloxacin hydrochloride soluble powder has the effects of anti-inflammation, sterilization, anti-virus, heart strengthening, cough relieving and allergic reaction resistance, can be used for improving the anti-disease immunity of poultry, repairing injured mucous membrane and effectively controlling secondary infection, and has an effective treatment effect to respiratory diseases of poultry.

Description

technical field [0001] The invention relates to a medicine for poultry, in particular to a compound levofloxacin hydrochloride soluble powder for treating poultry respiratory diseases. Background technique [0002] Poultry respiratory diseases refer to diseases with obvious respiratory symptoms (such as sneezing, snoring, wheezing, nose throwing) or mainly respiratory symptoms (such as Newcastle disease, influenza, bronchitis, throat transmission, slow breathing, etc.). Therefore, it can be said that respiratory disease is a general term for a class of diseases. Although these diseases all show respiratory symptoms, their etiology is different and quite complicated. In the poultry industry, especially the broiler industry, respiratory diseases are the most difficult and troublesome diseases, and they are also the most concerned by the majority of farmers, because such diseases are not only difficult to diagnose and treat, but also very easy to obtain. Almost every batch of c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/484A61K9/14A61P11/00A61K35/56A61K31/7052A61K31/5383A61K31/505A61K35/65
Inventor 刘长斗
Owner NANYANG XINXIANFENG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products